Parmax Pharma Ltd — Updates, 18-07-2025: Company Update

Parmax Pharma Limited has confirmed its compliance regarding the dematerialization of securities for the quarter ended June 30, 2025. The company, based on its Registrar and Share Transfer Agent's confirmation, ensures that all physical shares received for conversion into electronic format were promptly processed. This includes mutilation, cancellation, and updating depository records within the set timelines. Furthermore, all dematerialized securities are properly listed on the stock exchanges. This routine update highlights the company's efficient and compliant handling of investor share records, maintaining market integrity and ease of trading for shareholders.